These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25111361)

  • 1. [Conflicting Rules and Incentives for Health Promotion and Prevention in the German Statutory Health Insurance (GKV)].
    Bödeker W; Moebus S
    Gesundheitswesen; 2015 Jun; 77(6):397-404. PubMed ID: 25111361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors Influencing Participation in Financial Incentive Programmes of Health Insurance Funds. Results of the Study 'German Health Update'].
    Jordan S; von der Lippe E; Starker A; Hoebel J; Franke A
    Gesundheitswesen; 2015 Nov; 77(11):861-8. PubMed ID: 25536225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance and Implementation of Prevention in Germany--A Nationwide Survey of Decision-makers in the GKV-Spitzenverband and Political Decision-makers].
    Pawils S; Boettcher A; Metzner F; Plaumann M; Walter U
    Gesundheitswesen; 2015 Sep; 77 Suppl 1():S12-3. PubMed ID: 26406532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention and health promotion as a responsibility of legal health insurance--exemplified by a local insurance bureau].
    Ollenschläger G; Denecke A
    Gesundheitswesen; 1994; 56(8-9):423-9. PubMed ID: 8000163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we legally pay people for being good? A review of current federal and state law on wellness program incentives.
    Klautzer L; Mattke S; Greenberg M
    Inquiry; 2012; 49(3):268-77. PubMed ID: 23230706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morbidity and healthcare differences between insured in the statutory ("GKV") and private health insurance ("PKV") in Germany. Review of empirical studies].
    Huber J; Mielck A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):925-38. PubMed ID: 20853090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preventive medicine: With or without a spoonful of sugar].
    Grabfelder M
    MMW Fortschr Med; 2016 Mar; 158(4):68-70. PubMed ID: 27119892
    [No Abstract]   [Full Text] [Related]  

  • 8. [Expenditures of The German Statutory Health Insurance for Health Promotion and Disease Prevention 2012-2017: Positive Effects Due To The Disease Prevention Law?].
    Bödeker W; Moebus S
    Gesundheitswesen; 2020 Mar; 82(3):282-287. PubMed ID: 30822817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention as a pension insurance task: innovative models complementing proven concepts].
    Moser NT; Fischer K; Korsukéwitz C
    Rehabilitation (Stuttg); 2010 Apr; 49(2):80-6. PubMed ID: 20446190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low demand for substitutive voluntary health insurance in Germany.
    Thomson S; Busse R; Mossialos E
    Croat Med J; 2002 Aug; 43(4):425-32. PubMed ID: 12187520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the legal basis for health prevention and promotion in the school laws of the federal states in Germany].
    Niehues C; Höldke B; Gericke CA
    Gesundheitswesen; 2006 Feb; 68(2):101-9. PubMed ID: 16482490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incentive for Regional Risk Selection in the German Risk Structure Compensation Scheme].
    Wende D
    Gesundheitswesen; 2017 Oct; 79(10):816-820. PubMed ID: 28329873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary analysis of short-term financial implications of a prevention bonus program: first results from the German Statutory Health Insurance.
    Stock S; Stollenwerk B; Klever-Deichert G; Redaelli M; Büscher G; Graf C; Möhlendick K; Mai J; Gerber A; Lüngen M; Lauterbach KW
    Int J Public Health; 2008; 53(2):78-86. PubMed ID: 18681336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cannabis-derived medicines for the treatment of chronic pain : Problems resulting from medical appraisals in the experience of the Medical Advisory Board of the Statutory Health Insurance Funds North].
    Heidbreder M; van Treeck B
    Schmerz; 2019 Oct; 33(5):437-442. PubMed ID: 31531729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S. 1944. The Health Promotion and Disease Prevention Act of 1991: an urgent appeal for immediate action.
    J Public Health Policy; 1991; 12(4):425-42. PubMed ID: 1802887
    [No Abstract]   [Full Text] [Related]  

  • 16. Mandatory high-risk pooling: an approach to reducing incentives for cream skimming.
    van Barneveld EM; van Vliet RC; van de Ven WP
    Inquiry; 1996; 33(2):133-43. PubMed ID: 8675277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potentials of and approaches to prevention. Current developments in Germany].
    Apitz R; Winter SF
    Internist (Berl); 2004 Feb; 45(2):139-47. PubMed ID: 14991155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to promote prevention--economic incentives or legal regulations or both?
    Torén K; Sterner T
    Scand J Work Environ Health; 2003 Jun; 29(3):239-45. PubMed ID: 12828394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention and law. The legal regulation of prevention in health care].
    Koyuncu A; Kirch W
    Med Klin (Munich); 2009 Sep; 104(9):704-9. PubMed ID: 19779675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carrot, the stick and the general practitioner: how have changes in financial incentives affected health promotion activity in general practice?
    Langham S; Gillam S; Thorogood M
    Br J Gen Pract; 1995 Dec; 45(401):665-8. PubMed ID: 8745865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.